2nd ADC Linker & Conjugation 2023
2023-08-22 - 2023-08-24 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC field, showing how they are being used as key levers for ADC drug developers to pull to create ADCs with a widened therapeutic index.
The inaugural ADC Linker & Conjugation Summit has been specifically designed to drive innovations in linker and conjugation chemistries that result in stable ADCs, with low aggregation and controlled release, which can be replicated at scale.
See the complete event guide here.
Here’s a snapshot of our speaker faculty, including expert industry leaders such as:

Sayumi Yamazoe, Senior Principal Scientist, Bristol Myers Squibb
Romas Kudirka, Director, Chemistry & Bioconjugation, Bolt Biotherapeutics
Donglu Zhang, Senior Fellow, Genentech
Paul Song, Chief Scientific Officer, Genequantum
Patrick Higgs, Principal Scientist, Chemistry, Iksuda
Noah Bindman, Principal Scientist, Seagen
Marc-André Kasper, Director, Chemistry & Early Discovery, Tubulis
Paul Sauter, Director, Chemistry, VERAXA

…and many more!
Find the full list of speakers and session details here.
Be part of the first industry-dedicated meeting for professionals just like you, interested in learning about developments in the field of ADC linkers and conjugations, and overcoming common challenges with stability.

RNA Assay Development & Screening Summit
2023-08-23 - 2023-08-24 | The Bostonian Boston, 26 NORTH STREET, BOSTON, MA, 02109, United States
Bringing together technical experts from biopharma and academia, the brand-new RNA Assay Development & Screening Summit has been curated to support in-house assay development and screening strategies to find new RNA targets, and ultimately determine biological effect in a manner that supports progression from early discovery to drug candidate.
Developed in collaboration with experts in the field, join 60+ key opinion leaders from the likes of Arrakis Therapeutics, Expansion Therapeutics and NextRNA at the first technical RNA meeting of its kind!
Come away with actionable insights after deep diving into the latest technical expertise and explore learnings from data-driven case studies.
Don’t miss this unique opportunity expand and validate your assay and screening strategies and accelerate the path to the clinic! Learn more – https://ter.li/8fsu01

8th CAR-TCR Summit
2023-08-29 - 2023-09-01 | Hynes Convention Center, 900 Boylston St, Boston, MA, 02115, United States
Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.
This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.
The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.
Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.
To know more visit: https://ter.li/ztgick

2nd Oligonucleotides CMC & Analytical Development Summit 2023
2023-08-29 - 2023-08-31 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for long-term scalable manufacturing looks to propel oligonucleotide development to patients at a much faster rate.
The 2nd Oligonucleotides CMC & Analytical Development Summit returns this August to Boston. 70+ industry leaders will unite at this unique forum dedicated to CMC and Analytical Experts.
Across 3 days, senior leaders will leverage knowledge and share thought leadership focused on improving analytical characterization, effectively preparing CMC data for IND filing and scaling up with long-term manufacturing in mind.
Built with experts from AstraZeneca, Alexion Pharmaceuticals, Biogen , revolutionize your drug development protocols by keeping your finger on the pulse at this hotly anticipated summit.

Explore analytical control strategies for therapeutic oligonucleotides to ensure safety and quality with regulatory compliance
Overcome the challenges of capacity when out-sourcing to propel and expedite oligonucleotide development
Get interactive in roundtable discussions, picking the brains of your peers and expert speakers on how biopharma is currently navigating the regulatory landscape
Facilitate cost-efficient large-scale production of oligonucleotides now we are moving into larger patient populations and non-rare disease indications
Turbocharge novel and complex oligonucleotide development in an in-depth workshop outlining CMC, Analytical Characterization and Impurity Control of conjugates

Download your Full Event Guide Here for more details on what you can expect at the 2nd Oligonucleotides CMC & Analytical Development Summit. Including the expert speaker faculty, a full in-depth agenda and the incredible networking and collaboration opportunities on offer this year.

3rd Inner Ear Disorders Therapeutics Summit
2023-08-29 - 2023-08-31 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss.
However, in a space that has also had to battle with multiple clinical failures, there’s a genuine need for the industry to unite and overcome the specific obstacles that are currently acting as a barrier to late-stage clinical trials and through to approval.
That’s why the 3rd Inner Ear Disorders Therapeutics Summit is back this summer, bringing together the community to collectively accelerate development of drug-based approaches, sharing case studies and data-driven insights into optimizing preclinical programs and designing translational studies to ultimately validate clinically relevant targets.
This meeting will leverage the latest biotech and academic innovation alongside big pharma experience to address the technical and strategic challenges in delivering a safe and effective therapy to the inner ear.
What to expect from the 2023 meeting:

Explore how to improve clinical trial design to increase the number of clinical trials achieving regulatory approval
Delve into the numerous delivery methods being employed in industry and explore how to optimize delivery to the inner ear
Evaluate the current opportunities and limitations of using animal models to accurately predict preclinical efficacy and translational success
Leverage valuable insights from VC investors to understand the key considerations made when investing in or forging partnerships with biotechs focussing on inner ear disorder therapeutics
Navigate the complex landscape of improving the diagnostics of inner ear disorders by developing a robust diagnostic toolbox and strategizing how to supplement patient-reported outcome measures

View the full agenda here: https://ter.li/a2ivra

5th Exosomes Based Therapeutic Development Summit
2023-09-05 - 2023-09-07 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications.
This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and potency assays to enable robust translation into the clinic.
This is the most comprehensive, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes, achieve GMP manufacturing of EVs for clinical applications, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization.
The 2023 conference covers:

Emerging standardized analytical strategies for optimized characterization, purification, and isolation to improve batch consistency and reproducibility towards successful scale-up
Key pre-clinical and clinical updates across a range of therapeutic areas
The latest advancements of targeted delivery and therapeutic payloads
The challenges of large-scale manufacturing
Navigating the complex regulatory landscape across the drug development timeline

View the full agenda here: https://ter.li/q4fnpd

4th Annual Gene Therapy Immunogenicity Summit 2023
2023-09-05 - 2023-09-07 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all making strides with improving risk assessments, monitoring, and mitigating against AAV gene therapy immunogenicity.
Registering for 2023 will grant you access to keynote plenaries from leading gene therapy figures, deep-dive discussions into pressing preclinical and clinical developments, and highly appraised networking opportunities with 150+ of your peers, all to leave you with the actionable tools, insights, and connections you need to enhance your immunogenicity-focused work.
To know more visit: https://ter.li/vk8xwq

13th World Clinical Biomarkers & CDx Boston 2023
2023-09-05 - 2023-09-08 | Omni Boston Hotel at the Seaport, 450 Summer Street, Boston, MA, 02210, United States
The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.
Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.
To know more visit: https://ter.li/849j6q

7th Complement-Based Drug Development Summit
2023-09-11 - 2023-09-13 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this year’s Event Guide below!
7th Complement-Based Drug Development Summit
September 11-13, 2023
View Agenda
Reuniting experts across Nephrology, Neurology, Ophthalmology, and Haematology, join the leading companies showcasing the latest preclinical and clinical progress for complement-based therapeutics.

With 30+ expert speakers from: AGTC, Alexion, Alnylam, Amgen, Annexon, Apellis – and that’s just the A’s!
Covering more complement targets than ever before including C5aR2, Factor Bb and Combination Therapy, alongside an increased coverage of diseases
Full of content for your whole team covering the most pressing challenges – from evaluating the value proposition of different fragments to target to designing clinical trials with high-risk patient populations

​​​​View the full list of sessions and expert speakers here.
​​​​​​This world-class speaker faculty will evaluate the entirety of the complement landscape, from scientific understanding to strategic, commercial intelligence. This means that no matter your role in the field, you’ll leave with tangible insights to further develop your complement pipeline.

LNP Characterization & Analytical Development Summit
2023-09-12 - 2023-09-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance
With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and strengthen your lipid nanoparticle characterization, bioanalytical and assay development competencies.
With unmissable case studies from the likes of Pfizer, Moderna, AstraZeneca, Ultranegyx, Merck and SINTEF, this is the definitive forum to benchmark and learn with the LNP community who unite for the first time.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Analyze LNP structure and morphology to relay into functional data and analytical practices with Ultragenyx and Pfizer
Optimize the characterization of payloads to foresee the outcome of the LNP complex with Hopewell Therapeutics, Beam Therapeutics and Moderna
Develop assays which align with mechanisms of action and portray total functionality of the LNP with NIST, Editas Medicine and AstraZeneca

Don’t miss this opportunity to supercharge your analytics, and together with 60+ characterization and analytical scientists, get inspiration to derive best practice, and support next generation of therapeutics to patients with safety and efficacy.
To know more visit: https://ter.li/z7dmih

3rd Rare & Genetic Kidney Disease Drug Development Summit
2023-09-12 - 2023-09-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to give industry the opportunity to unite towards a shared goal and share strategic insights to move from bench to bedside and bring efficacious therapies to patients faster.
To know more visit: https://ter.li/jy2ot0

Wearable Injectors and Connected Devices USA
2023-09-13 - 2023-09-14 | Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, 02199, United States
Wearable Injectors and Connected Devices USA
Conference: September, 13 – 14 2023
Boston, USA
Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL
Advancing digital health and on-body drug delivery devices for enhanced patient experience
Following the success of the Wearable Injectors and Connected Devices Europe conference, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma, Biotech and Device Developers in the USA.
As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices with case studies and an FDA keynote on cybersecurity.
As part of SAE Media Group’s leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2023!
Key Reasons to Attend:

Discover the latest advances in wearable injector design and development as well as emerging technologies for improved drug delivery
Understand and gain insight into the regulations surrounding electronic devices and wearable injectors such as labelling requirements and clinical study expectations
Delve into the digital integration of medical devices for improved user experience and strategies to ensure connected ecosystems are safe with an FDA Cybersecurity update
Benchmark against connected injector case studies and gain insight into key considerations during development such as battery selection
Engage in the latest strategies for implementing user centricity into device design to meet patient needs and increase adherence

WHO SHOULD ATTEND?
Device Developers
Combination Product Developers
Smart Packaging Developers and Designers
Smart Device Developers
Drug- Delivery Developers
Connected/Digital Health Developers

7th IPF Summit
2023-09-19 - 2023-09-21 | Westin Boston Seaport, 425 Summer Street, Boston, MA, 02210, United States
FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to Phase 3 trials to get the next disease-modifying drug to the patients in need.
The 7th IPF Summit (September 19-21 | Boston) returns at this crucial stage for the drug development and academic communities to come together to address R&D bottlenecks, troubleshoot key discovery challenges, and share exclusive data to accelerate the latest ideas and innovations in the IPF field and supercharge a new era of IPF therapeutics.
If you haven’t yet seen the line-up of 42+ expert speakers, take a look at the full program in the event guide!
Are you looking to address and solve challenges with IPF therapeutic development, such as:

Understanding cell cross-talk in the lung pathobiology of IPF, including epithelial and endothelial cells
Harnessing precision medicine for IPF including patient selectivity, combinational therapies, and biomarkers
Whether to incorporate imaging into your preclinical and clinical development and the potential of using imaging as an endpoint in IPF?

Then this is the event for you! This is your unique opportunity to leverage knowledge from world-leading IPF industry experts and KOL academics on the latest developments to overcome, discovery, preclinical, translational, and clinical, challenges of IPF therapeutic development for successful advancement of therapeutic candidates to in-human studies and beyond.
Join experts from the likes of Boehringer Ingelheim, Genentech, Pfizer, AstraZeneca, BMS, Pliant, Galecto, Vicore, Avalyn, Pieris, Moderna, Takeda and more who have already saved their places at the meeting.
See pricing and registration options here!

2nd mRNA Process Development & Manufacturing Summit
2023-09-26 - 2023-09-28 | Boston Convention and Exhibition Center (BCEC), 415 Summer Street, Boston, MA, MA 02210, United States
Returning to Boston as the world’s only industry-leading meeting focused on mRNA process development and manufacturing, join 200+ VPs, Directors and Heads of Process Development, MSAT, Technical Operations, CMC and more from large pharma, innovative biotechs, and academia.
Download the program here: https://ter.li/5o4hdl
This must-attend meeting will provide you with technical insight and know-how from the largest process development and manufacturing speaker faculty to date, enabling you to revolutionize your processes for effective industrialization.
Spanning three tracks dedicated to Research Scale, IND-Enabling & Clinical Scale, and Commercial Scale, this year’s meeting will dive deep into the challenges, requirements, innovations and opportunities to improve your design, development and scale-up solutions from drug substance to drug product for regulatory and market readiness.
Register here: https://ter.li/nu15iq

5th TIL Therapies Summit
2023-10-02 - 2023-10-04 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
With the first commercial TIL therapy brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, the race is on for the next generation of modified TIL to enter the clinic.

Returning as the only forum to address bottlenecks in end-to-end TIL development, the 5th TIL Therapies Summit is designed exclusively for TIL experts to fast-track your program into the clinic and beyond.
Unite with this niche community across industry and academia as pioneers from Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics and Lyell Immunopharma share clinical updates, next-gen engineering, and novel innovations to turbocharge preclinical and clinical development of safe, scalable and effective TIL therapies.
With 23+ expert speakers, 8 new companies and a brand-new Manufacturing & Characterization Bootcamp, you won’t want to miss this unrivalled opportunity to connect and collaborate with industry leaders.
Don’t let your team get left behind! Join us as we accelerate the next wave of TIL therapies into the clinic and beyond. Find out more – https://ter.li/mk23q3.

Wearable Injectors and Connected Devices Conference & Expo
2023-10-09 - 2023-10-10 | Hilton London Kensington, 179-199 Holland Park Ave, London, W11 4UL, United Kingdom
Wearable Injectors and Connected Devices Conference & Expo
9 – 10 October 2023 | London, UK
http://www.wearable-injectors.co.uk/PharmaJournalist-EL
Strategies to advance digital health and on-body drug devices for large volume delivery
SAE Media Group are proud to announce the 4th annual Wearable Injectors and Connected Devices conference. As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity.
The conference will delve into on-body device design and development, enhancing digital connectivity for injectable devices, strategic approaches to wearable device design, regulatory considerations and primary container considerations for large volume delivery systems.
As part of SAE Media Group’s leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in October 2023!
Benefits of Attending:

Engage with key regulatory updates surrounding digital health and medical devices
Discover advances in device design and development for large volume delivery via on-body injectors
Explore the key drivers of novel drug products for the development for on-body injectors
Hear insights into the growing potential of digital health to improve patient experience and treatment
Develop your understanding of design strategies for connectivity and digital health

Delegates will have the opportunity to network with the following companies:

Johnson & Johnson
Biogen
AstraZeneca
Merck KGaA
Novartis
Novo Nordisk
Boehringer Ingelheim

And many more!!
Who Should Attend:

Executives, Directors, VPs, Heads, Principals, Managers of:
Drug-Delivery Developers
Autoinjectors
Device Engineering
Human Factors
Injectables
Packaging
Regulatory Affairs
Connectivity
Medical Device Data
Novel Product Technology
Smart Device Developers
Device Safety Solution Providers
or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals, biotech, device developers and solution providers.

The two-day conference will bring you high-quality insights and industry connections on the latest advances in wearable injectors and connectivity, and a platform for exchanging ideas.

6th Neuropsychiatric Drug Development Summit
2023-10-10 - 2023-10-12 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The Definitive Industry Forum for Spearheading Non-Psychedelic & Psychedelic R&D
2023 is booming with novel psychiatric R&D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on the horizon, as unmet needs in PTSD, bipolar, anxiety, schizophrenia, depression, and ADHD become greater and greater. There is, therefore, a huge deal of novel and promising research to be discussed this October at the 6th Neuropsychiatric Drug Development Summit.
With discovery, preclinical, translational, and clinical scientists from the likes of Biogen, Otsuka, AbbVie, Genentech, Lundbeck, Delix Therapeutics, Atai, Gilgamesh, and Cerevel Therapeutics, don’t miss the field’s favorite conference, specifically dedicated to biopharma’s most pressing challenges of de-risking the translational gap and advancing transformative neuropsychiatric candidates through the clinic.
To know more visit: https://ter.li/sar413

14th World ADC San Diego 2023
2023-10-16 - 2023-10-19 | Sheraton San Diego Hotel and Marina, 1380 Harbor Island Dr, San Diego, CA, 92101, United States
The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion, and BMS’ $1 billion+ pact with Tubulis. There has been no better time to reunite the World ADC community and invest in progressing ADCs to front line treatments for patients.
The highly anticipated 14th World ADC San Diego (October 16-19, 2023 | San Diego, CA) returns as the world’s largest industry-dedicated discussion and networking forum addressing and overcoming the challenges in end-to-end ADC development.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers.
Whether you’re new to the field or an ADC guru, there is something for everyone included in this year’s agenda. Some of your must-attend talks per track include:

Discovery Chemistry: Join Christopher Marvin, Principal Research Scientist, AbbVie as he reviews the design and optimization of glucocorticoid receptor modulator payloads for Immunology ADCs
Cellular Biology: Discuss with Robert Lawrence, Principal Scientist, Seagen the influence of artificial intelligence on ADC target discovery
Translational: Review a best-in-class translational study with Meijuan Li, Vice President, Head of Translational Sciences & Biostatistics, Eisai Oncology
Clinical Lessons: Be the first to hear industry-changing clinical results from ImmunoGen, Byondis, Iksuda Therapeutics, Seagen, Bliss Bio, Genentech and Elucidia Oncology
Process and Analytical Development: Debate the key considerations for ADC comparability studies in a dedicated roundtable lead by ADC CMC expert, Julie Beaudet, CMC Staff Scientist, Regeneron Pharmaceuticals
Manufacturing and Supply Chain: Explore the manufacturing of novel dolaLock ADCs with supply chain architecture with Engin Ayturk, Executive Director, CMC Process Development, Mersana Therapeutics

Access to the complete agenda here including a 7-tracked seminar day and 10 industry-beating workshops.
Don’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had, and building momentum for the future of this innovative field.

2nd Operationalise: Early Access Programmes Europe Summit
2023-10-16 - 2023-10-18 | Hilton Canary Wharf, South Quay, Marsh Wall, London, E14 9SH, United Kingdom
The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide patients in Europe with early access to medicines.

This meeting provides a forum to address burning questions and share ideas on topics such as European regulatory guidelines, labelling, supply, and best practices around reimbursement, integrating of pre- and post-trial access programmes and scoping.
Providing practical, valuable case studies is this year’s expert speaker lineup including the likes of GlaxoSmithKline, Roche, Novartis, Sanofi, and many others! Visit our website to download a free copy of the full event guide to explore the jam-packed 3-day agenda and full speaker faculty.
Whether you’re a veteran at managing early access programmes and are looking to expand your geo, or a new entrant to the field, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2023 and beyond.
To know more visit: https://bit.ly/3K4BpqO

4th Commercializing Flow Chemistry Summit
2023-10-16 - 2023-10-18 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Scaling Flow Chemistry for Sustainability, Safety and Speed to Market
With the growing demand for better flow technology, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into transforming your process efficiency, emerging technology toolbox and economic gains through strategic flow chemistry.
With unmissable case studies from the likes of Novartis, Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Takeda, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Elevate Sustainability with Industry Leaders: Join forces with Merck, Eli Lilly and AbbVie to integrate sustainable practices seamlessly into your workflow, enhancing both environmental responsibility and operational excellence
Unlock Efficiency through Automation: Discover the power of automation in flow chemistry, following the footsteps of efficiency leaders like Sanofi, Takeda, and Boehringer Ingelheim, and optimize your processes for peak performance
Master Multi-Step Techniques: Gain expert insights from Boehringer Ingelheim on handling multi-step reactions in both flow and batch setups, fine-tuning your manufacturing processes for maximum efficiency and output

Don’t miss this opportunity to streamline your continuous chemistry research into scaled commercial applications, and together with 80+ process chemists, engineers, and modellers, go beyond reaction to work up optimization to develop winning processes quicker and expedite your drug development.
To know more visit: https://ter.li/jfxs1m

2nd Innate Killer Summit Europe 2023
2023-10-17 - 2023-10-19 | Crowne Plaza London, Royal Victoria Dock, Western Gateway, London, E16 1AL, United Kingdom
The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through effective and scalable engineering, engager and combination strategies that promote safe, potent and persistent innate immune therapies following application.
Don’t miss this chance to network with innate immune trailblazers from the likes of Sanofi, Takeda, Lift Biosciences, Mink Therapeutics, Affimed, Carisma Therapeutics, Arovella Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond. Learn more – https://ter.li/nkcwg3

11th IMPACCT: Real World Evidence Summit 2023
2023-10-23 - 2023-10-25 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured healthcare data and transform disease treatment.
Join 100+ senior leaders in RWE, RWD, real world analytics & epidemiologists from pharma and biotech to take part in this three-day summit with over 18 hours of exclusive content.
Don’t miss your unique opportunity to explore how to leverage RWE to target patient populations and drive DE&I into trials. For more information go to: https://ter.li/db1xte

Biosensors for Medical Wearables Conference and Expo
2023-10-23 - 2023-10-24 | COURTYARD BY MARRIOTT BOSTON DOWNTOWN, 275 Tremont St, Boston, MA, 02116, United States
Biosensors for Medical Wearables Conference and Expo
*In collaboration with Medical Design Briefs*
October 23-24, 2023 | Boston, MA, USA
http://www.biosensors-medical-wear.com/PharmaJournalist-WL
SAE Media Group’s 3rd Annual Biosensors for Medical Wearables Conference will be back for 2023 in Boston to bring together device developers, MedTech, component manufacturers and big pharma to share and discuss the exciting advances in the medical wearable technology landscape.
The wearable biosensors market has grown significantly in recent years leading to increasingly growing potential for medical applications and at home alternatives for patients. With growing applications and potential in remote patient monitoring, diagnosis, therapeutics and detection of disease, wearable sensors are attracting considerable interest due to their opportunities in better supporting patients, clinical outcomes and decisions. Furthermore, AI and connected technologies are furthering the potential opportunities of this industry. However, challenges including flexibility of wearable devices, the collection of clinical-grade data and advanced battery technologies still remain for the industry to overcome. This year’s conference looks to address these hot topics through case studies and industry insights.
This is a must attend event, giving you the chance to engage in the latest innovations that are accelerating the wearable biosensors industry. We hope to welcome you in October 2023!
Reasons to attend:

Benchmark against and explore the latest biosensor technologies for wearable medical devices from Abbott, Empatica and Hexoskin
Delve into the potential of wearable sensors and digital tools in decentralized diagnosis including a Johnson & Johnson case study on the Heartline project
Learn how game changing companies such as Philips and Medtronic are utilizing wearables to maximize remote patient monitoring opportunities for wider patient populations
Explore how AI and machine learning technologies are enabling optimized data collection and streamlined data analysis
Discover cutting-edge biosensor therapeutic applications for neurology with Neurasantys and a panel discussion on future medical opportunities

Who you can meet?

Andreas Caduff, Strategic Advisory Board, DiME
Lorelie Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (an Abbott Company)
Tim Callahan, VP Scientific Affairs, Philips
Kara Chappie, Director and Project Lead, Pfizer
Jason Case, Vice President, Research and Development, Patient Monitoring, Medtronic
James Mault, MD, Founder and CEO, BioIntellisense, Inc.
Jasmin Imsirovic, Associate Director, Takeda
Janet Nikolovski, New Venture Lead – Genitourinary Oncology, Johnson & Johnson

CRISPR-Based Therapy Analytical Development Summit
2023-10-30 - 2023-11-01 | Hilton Boston Bay Back, 40 Dalton St, Boston, MA, 02115, United States
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex CRISPR structures necessitate cutting-edge advancements in analytical methods and tools to effectively characterize the genome-edited products utilizing CRISPR technology.
As industry experts tread unchartered territory, the inaugural CRISPR-Based Therapy Analytical Development Summit has been convened, gathering more than 60 distinguished experts in analytical development devoted to the creation, refinements and implementation of more robust analytical tools specifically tailored to CRISPR-based constructs.
Within this intimate space, we will adopt a shared consensus and delve into a comprehensive array of analytical techniques central to any CRISPR-based toolkit. Topics of discussion will span pioneering technology that includes everything from novel methods to characterize the guide RNA and whole CRISPR complex, to the use of next-generation sequencing (NGS) to detect and assess off-targets for superior safety evaluations.
In response to the regulatory bodies’ insistence on high-quality data to substantiate the safety and efficacy of genome-edited products, this summit is imperative to all individual engaged in the development of analytical tools and methodologies utilizing CRISPR technology as we build for better guidance around CRISPR-edited products.
If your role centers around analytical expertise and gene edited specialization, this meeting will enable you to streamline your analytical development process and connect in a shared goal to deliver safer therapies, with superior therapeutic benefit to patients faster.
To know more visit: https://ter.li/28jg6x

5th Gene Therapy for Neurological Disorders Summit
2023-11-06 - 2023-11-09 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Accelerating More Transformative Gene Therapies for CNS Disorders
Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community.
The 5th Gene Therapy for Neurological Disorders Summit is your comprehensive 4-day event to stay ahead of cutting-edge developments, overcome delivery challenges, address translational bottlenecks, and create a bulletproof clinical development strategy, to propel the next wave of CNS gene therapies forward.
This summit will unite 200+ gene therapy and neurology leaders with a program designed to cater to everyone from Discovery through to Clinical Development; this is your only opportunity for a cover-to-cover discussion full of need-to-know and practical insights.
Now that the neurological gene therapy field has been given a renewed sense of direction, this is the opportunity for the community to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders.
To know more visit: https://ter.li/iblyl1

Extractables & Leachables Europe 2023
2023-11-06 - 2023-11-07 | Steinberger Airport Hotel, Stationsplein Zuid-West 951, 1117 CE Schiphol, Netherlands, 1117 CE, Netherlands
Join us at this year’s much-anticipated Extractables and Leachables Europe, taking place on 6-7 November 2023 in Amsterdam.
This year’s conference promises to once again provide you with everything you need to know about this ever-evolving sector. Extractables and leachables examination is continuously growing in importance. Given the current scrutiny paid by governing bodies including the FDA and MHRA, understanding the best practice and guidelines to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
Whatever your level or position, and whether you’re from a CRO, pharmaceutical manufacturer, packaging specialist, instrument or equipment manufacturer, research or academic institution, chemical company or OEM – this conference has something for everyone.
With speakers from reputable companies like Element, GSK Vaccines, Aptar Pharma, Octapharma, Sartorius Stedim Biotech and numerous others, the agenda is bursting with insights, helping the conference be the most exceptional one to date.
Described by a previous attendee as ‘the place to be for the E&L community’, this is a mist-attend event for anyone working in the industry.
Find out more here: https://www.eandl-conference.com/extractables-and-leachables-europe
In addition to organising the renowned E&L events in Europe, US and China, Smithers also have a long history in providing E&L and medical device testing across the globe. Find out more at www.smithers.com.

PURIFY’23
2023-11-07 | ITC KOHENUR, HYDERABAD, INDIA
PURIFY – Chromatography Purification Conclave
PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups!
The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification.
The attendees at PURIFY get exposed to a myriad of topics that could change the way they work…change the way they purify. New separation techniques and approaches, niche topics, deeper understanding of preparative and process chromatography and allied fields, and upcoming application areas that will provide quality substance to the discerning scientists. So, if you wish to get that additional gram, which is purer, in as less a time, with minimal resources…there will surely be something for you at PURIFY conclaves!
The annually occurring PURIFY Conclave is an initiative by Custage Marketing Solutions LLP, a Mumbai based company.
The PURIFY conclave is attended by analytical and research chemists, scientists with scale-up and process development knowledge, managers, group heads, natural product purification experts, experts from quality and manufacturing, academicians, policy makers, supply chain heads etc. of this pharmaceutical – APIs, peptides, proteins, oligonucleotides, chiral molecules, bio-pharmaceutical, fine chemicals, environmental studies, food and beverage, polymers, biotechnology, cosmetics and fragrance to understand the advancements in chromatography platforms.
So, the purification expert in you will surely get answers to the daily challenges faced for you in your laboratories. And what’s more, the knowledge comes to you from dignitaries who are institutions on their own in chromatography purification and related.
To know more visit: https://www.purifyconclaves.com/

7th Microbiome Movement – Human Nutrition Summit
2023-11-07 - 2023-11-09 | Westminster Hotel, 550 W Mt Pleasant Ave, Livingston, NJ, 07039, United States
The 7th Microbiome Movement – Human Nutrition Summit will unite 100+ human nutrition leaders this November in Livingston, NJ to optimize product development and consumer acceptance of microbiome-based food and nutritional products. Join the only industry led meeting dedicated to moving the needle on scientifically validated, microbiome modulating, nutritional product development.
From developing pre-, pro-, or post-biotics, functional food, microbiome modulating ingredients, to other interventions that provide microbial-mediated health benefits, this meeting offers unrivalled opportunities for those working in the microbiome human nutrition space.
Join us in Livingston, NJ, this November to hear invaluable insights from the likes of Bifidice, Danone, Holobiome, ADM, Immune Biome, and more!
View the full event guide here: https://ter.li/2ppxtz
Offering earlybird rates, exclusive group discounts and a brand-new, post-conference consumer focus day, now is the time to register. Don’t miss out, secure your place now: https://ter.li/8algsb

5th Annual Gene Therapy Analytical Development Summit 2023
2023-11-27 - 2023-11-30 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.
In this context, the 5th Annual Gene Therapy Analytical Development is returning in 2023, uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality, consistency, safety, and efficacy of gene therapy products.
Join biopharma colleagues specializing in bioassays, molecular biology, physicochemical properties, quality, process development and regulation across 4 days of niche, expert presentations, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer, efficacious therapies to patients more quickly and effectively.
To know more visit: https://ter.li/qf50s3

7th Obesity & NASH Drug Development Summit
2023-11-27 - 2023-11-29 | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
Eli Lilly’s ‘triple G’ drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new record for the obesity field has been set and the time to get ahead of the curve is now. In parallel, we’re witnessing history being made with the world’s first approved NASH treatment potentially being right around the corner with Madrigal’s THR β-selective agonist, marking this year a pivotal time for the metabolic field to forever elevate the approach towards drug development and overcome regulatory barriers.
Reuniting metabolic experts to enable the assessment of the competitive landscape, the 7th Obesity & NASH Drug Development Summit is uniquely positioned to capture all the latest breakthroughs and research you need to join the race and commercialize your GLP-1 RAs, tri-agonists, dual agonists, tetra-specific drugs, glucocorticoid receptor modulators and more.
2023 is an exciting year due to the evolution in digital pathology, artificial intelligence, omics, multifunctional molecules, non-invasive biomarkers, target discovery and liver models, this is your timely meeting dedicated to bringing the metabolic community closer to navigate the route to even more approvals. However, as industry gets closer to successes, challenges remain.
Keen to overcome these discovery, regulatory, clinical, and commercial hurdles?
Join 160+ experts at the largest gathering of obesity and NASH industry drug developers from Eli Lilly, Novo Nordisk, Madrigal, Akero, Gilead, Pfizer, AstraZeneca, Gilead, Inventiva and many more to cultivate sustainable weight-loss drugs and navigate the route towards the first approval in NASH. Don’t miss your opportunity to hear from 42+ metabolic experts over 3 jam-packed days with all the latest end-to-end updates to advance your drug development.
To know more visit: https://bit.ly/465Aa3m
